Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-16

Clinical Trial Update: ACT vs CQ With Tafenoquine for P. Vivax Mono-infection [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing artemisinin-based combination therapy (ACT) versus chloroquine with tafenoquine for Plasmodium vivax malaria mono-infection; re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Artemisinin-based combination therapy (ACT)
  • Chloroquine (chloroquine)
  • Tafenoquine (tafenoquine)

Snippet

Sponsor: Shoklo Malaria Research Unit | Conditions: Malaria, Malaria, Vivax | Phase 4 | Status: RECRUITING